Holding(s) in Company
Fusion Antibodies plc has announced that Simon Peace now holds 5,121,744 ordinary shares, representing approximately 4.09 per cent. of the Company's issued share capital, following a share purchase on 29 June 2026. This disclosure updates the market on significant shareholdings within the company.
Select text to share a quote on X · sign in to keep highlights & notes in your FAB notes
Holdings in Company
Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, has been informed today that, following a purchase of shares on 29 June 2026, Simon Peace holds 5,121,744 ordinary shares of 4 pence each in the Company, representing approximately 4.09 per cent. of the Company's issued share capital.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.